Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Given Average Rating of “Hold” by Brokerages
Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) has earned a consensus rating of “Hold” from the five ratings firms that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the […]
4 Oct 08:22 · The Markets Daily